| Catalog No. | HX913016 |
|---|
| Species reactivity | Human |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Host species | Human |
|---|
| Isotype | IgG4-kappa |
|---|
| Expression system | Mammalian Cells |
|---|
| Clonality | Monoclonal |
|---|
| Target | IL13R, IL-13R subunit alpha-1, IL13RA1, IL13RA, IL-13RA1, CD213a1, Interleukin-13 receptor subunit alpha-1, IL-13 receptor subunit alpha-1, CT19, IL-13R-alpha-1, Cancer/testis antigen 19 |
|---|
| Concentration | 0.7mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G, purified from cell culture supernatant. |
|---|
| Accession | P78552 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -766°C. |
|---|
| Alternate Names | ASLAN-004,ASLAN004,CSL-334CAS:2445460-16-0 |
|---|
| Background | Eblasakimab (ASLAN004; CSL-334) is a human IgG4 antibody that specifically targets IL13RA1 and is primarily expressed by CHO-K1 cells. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
